drug
(amivantamab + hyaluronidase (human recombinant))
Marketedupdated 3mo agoby $JNJ JOHNSON & JOHNSON
Approvedcommunity read0 votes
🐶 often sniffed alongside
top 5indications
investigational
NSCLC
all catalysts(2)
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 16m ago
Found something off?
comments(0)
5-min edit window · permanent after that